Microtome Market is Growing at a Promising CAGR of 6.1% During Forecast 2019-2025

Market Forecast:
A microtome is a tool used to cut extremely thin sections of tissue samples. Microtomes help in extremely fine cuts that are important for preparations used in microscopy. Different kinds of microtomes made up of metals and glass are used depending on the type of specimen and the desired thickness.
The global Microtome Market is projected to register a CAGR of 6.1% and accounted for USD ~120 million in 2018.
The growth of the global microtome market is driven by various factors such as an increase in the incidence of chronic disorders, increasing prevalence of lifestyle diseases, and increasing mergers & acquisitions by prominent players in the market. However, lack of skilled workforce is projected to hamper the growth of the global microtome market.
The global microtome market is currently dominated by several market players such as Danaher Corporation, Thermo Fisher Scientific, and Sakura Finetek, among others. Additionally, growing growth strategies adopted by market players are driving the growth of the market. For instance, in 2018, Sakura Finetek launched Accu-Cut SRM 300 LT, manual microtome.
Key Players:
·         Amos Scientific Pty Ltd
·         Danaher
·         Diapath S.p.A.
·         Histo-Line Laboratories
·         Jinhua YIDI Medical Appliance Co
·         MEDITE GmbH
·         Boeckeler Instruments
·         Sakura Finetek
·         SLEE Medical GmbH
·         Thermo Fisher Scientific
Segmentation:
·         The Global Microtome Market has been segmented based on product, application, technology, and end-user.
·         The market, based on product, has been divided into instruments and accessories. Instruments are further sub-segmented into rotary microtomes, cryostat microtomes, vibrating microtomes, and others. Instruments are expected to hold the largest share, due to the commercial availability of these systems and their high adoption rate due to ease of handling.
·         In terms of application, the global microtome market has been segmented into disease diagnosis and medical research. Disease diagnosis takes up the largest share due to the increasing number of tissue examinations in research laboratories and hospitals owing to rising awareness about the benefits of early diagnosis of diseases like cancer.
·         In terms of technology, the global microtome market has been segmented into manual, semi-automated microtomes, and fully automated microtomes. The fully automated segment held the majority share due to rising demand for technologically advanced products and its ability to show the highest precision in section thickness. Additionally, fully automated microtomes do not require tedious manual adjustments.
·         In terms of end-user, the global microtome market has been segmented into hospital laboratories and clinical laboratories. Hospital laboratories take up the largest share. The positive growth of hospitals is attributed to factors such as a high volume of routine tissue examinations performed in hospital-based laboratories across the globe and growing patient population.
Regional Analysis:
Americas: The Americas holds the largest share in the global microtome market.
North America: The North American market for Microtome is growing at a substantial rate. This is attributed to the increasing number of patients affected by chronic disorders and the growing presence of major market players.
US: Major market players are involved in strategic partnerships and product launches to come up with innovative products. Moreover, the rising cases of cancer among the US population is driving market growth. For instance, in May 2018, Leica Biosystems, part of Danaher, introduced new line of rotary microtomes to its full line of histology equipment and consumables. This new product includes HistoCore BIOCUT, HistoCore MULTICUT, and HistoCoreAUTOCUT clinical microtomes.
Latin America: Improving investments in research & development by market players is expected to fuel the growth of the market in this region.
Europe: The growing awareness among the population regarding chronic disorders is expected to boost the growth of the regional market

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more